Product Name
ALPHA ELASTIN (ELN), Polyclonal Antibody
Full Product Name
RABBIT ANTI HUMAN ALPHA ELASTIN
Product Gene Name
anti-ELN antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P15502
Species Reactivity
Bovine, Tree shrew
Form/Format
Purified
Purified IgG - liquid
Concentration
IgG concentration 5.0 mg/ml (lot specific)
Perservative Stabilisers
0.09% Sodium Azide (NaN3)
Preparation
Buffer Solution
Phosphate buffered saline
Preparation and Storage
Store at 4 degree C or at -20 degree C if preferred. Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Shelf Life: 18 months from date of despatch.
Other Notes
Small volumes of anti-ELN antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-ELN antibody
Rabbit anti Human Alpha Elastin antibody recognizes alpha and beta human elastin, also known as Tropoelastin. Elastin is a major structural protein expressed within the outer myometrial smooth muscle and throughout the arteriolar tree of uterus. It is also expressed in the large arteries, lung and skin. This antibody is also known to cross react with bovine alpha elastin.
Applications Tested/Suitable for anti-ELN antibody
ELISA (EIA), Immunohistology Paraffin*
Application Notes for anti-ELN antibody
ELISA: In a simple ELISA, with 1 ug of native antigen coated per well, the 50% OD was observed at an antibody dilution of 1/8K. Under the same conditions, the end point was observed at 1/200K.
Immunohistology - Paraffin: Application Note: Fixation with 10% formalin is recommended. Brief digestion with hyaluronidase or trypsin aids antigen retrieval.
NCBI/Uniprot data below describe general gene information for ELN. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000492.2
[Other Products]
NCBI GenBank Nucleotide #
NM_000501.3
[Other Products]
UniProt Primary Accession #
P15502
[Other Products]
UniProt Secondary Accession #
O15336; O15337; Q14233; Q14234; Q14235; Q14238; Q6P0L4; Q6ZWJ6; Q75MU5; Q7Z316; B3KTS6[Other Products]
UniProt Related Accession #
P15502[Other Products]
Molecular Weight
60,980 Da[Similar Products]
NCBI Official Full Name
elastin isoform a
NCBI Official Synonym Full Names
elastin
NCBI Official Symbol
ELN??[Similar Products]
NCBI Official Synonym Symbols
WS; WBS; SVAS
??[Similar Products]
NCBI Protein Information
elastin; tropoelastin
UniProt Protein Name
Elastin
UniProt Synonym Protein Names
Tropoelastin
UniProt Gene Name
ELN??[Similar Products]
UniProt Entry Name
ELN_HUMAN
NCBI Summary for ELN
This gene encodes a protein that is one of the two components of elastic fibers. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Deletions and mutations in this gene are associated with supravalvular aortic stenosis (SVAS) and autosomal dominant cutis laxa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
UniProt Comments for ELN
elastin: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. Defects in ELN are the cause of cutis laxa, autosomal dominant, type 1 (ADCL1). A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. Additional variable clinical features are gastrointestinal diverticula, hernia, and genital prolapse. Rare manifestations are pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and emphysema. Defects in ELN are the cause of supravalvular aortic stenosis (SVAS). SVAS is a congenital narrowing of the ascending aorta which can occur sporadically, as an autosomal dominant condition, or as one component of Williams-Beuren syndrome. ELN is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of ELN may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease. Belongs to the elastin family. 13 isoforms of the human protein are produced by alternative splicing.
Protein type: Secreted, signal peptide; Extracellular matrix; Secreted
Chromosomal Location of Human Ortholog: 7q11.23
Cellular Component: proteinaceous extracellular matrix; extracellular region
Molecular Function: protein binding; extracellular matrix structural constituent
Biological Process: extracellular matrix disassembly; cell proliferation; extracellular matrix organization and biogenesis; organ morphogenesis; blood circulation; respiratory gaseous exchange
Disease: Cutis Laxa, Autosomal Dominant 1; Williams-beuren Syndrome; Supravalvular Aortic Stenosis
Research Articles on ELN
1. the role of the Asp-72 site in stabilizing the N-terminal segment of human tropoelastin
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.